| 000 | 01201 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515082507.0 | ||
| 264 | 0 | _c20080110 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0163-7258 | ||
| 024 | 7 |
_a10.1016/j.pharmthera.2007.06.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClark, James E | |
| 245 | 0 | 0 |
_aPotential of p38-MAPK inhibitors in the treatment of ischaemic heart disease. _h[electronic resource] |
| 260 |
_bPharmacology & therapeutics _cNov 2007 |
||
| 300 |
_a192-206 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
| 700 | 1 | _aSarafraz, Negin | |
| 700 | 1 | _aMarber, Michael S | |
| 773 | 0 |
_tPharmacology & therapeutics _gvol. 116 _gno. 2 _gp. 192-206 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharmthera.2007.06.013 _zAvailable from publisher's website |
| 999 |
_c17294593 _d17294593 |
||